Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17386270 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments
Conditions: Age-related Macular Degeneration;   Pigment Epithelial Detachment;   Neovascular Macular Degeneration;   Wet Macular Degeneration
Intervention: Drug: ranibizumab
2 Active, not recruiting Study for Recalcitrant Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: aflibercept 2.0 mg

Indicates status has not been verified in more than two years